Hospital M&A update: 9 recent deals

Acquisition
Nine transactions involving hospitals and health systems were announced, finalized or advanced in the last week: 1. Ascension to sell 7 Wisconsin hospitals, 21 clinics to Aspirus Ascension Wisconsin plans to sell seven hospitals, 21 physician clinics and its patient transport services to Wausau, Wis.-based Aspirus Health. 2. SSM Health to sell 100-year-old Missouri hospital St. Louis-based SSM Health signed a definitive agreement to sell its 100-year-old Missouri hospital to Kansas City, Mo.-based Noble Health. 3. UPMC's acquisition of Ireland hospital approved Pittsburgh-based UPMC won approval to acquire a 105-year-old hospital in Kilkenny, Ireland. 4. MaineHealth adds Brunswick hospital Portland-based MaineHealth added a ninth hospital to its network this month, according to a disclosure notice published Jan. 13. 5. Tenet aims to acquire up to 40 surgery centers this year Tenet Healthcare, a 65-hospital system based in Dallas, plans to acquire 25 to 40 ambulatory surgery centers this year, according to the company's presentation Jan. 12 at the J.P. Morgan Healthcare Conference. 6. CommonSpirit to sell 14 hospitals to Essentia Health Fourteen hospitals owned by Chicago-based CommonSpirit Health could join Duluth, Minn.-based Essentia Health as early as this summer. 7. Illinois hospitals merge, get new names St. Margaret's Hospital in Spring Valley, Ill., and Illinois Valley Community Hospital in Peru have consolidated their operations to form a regional healthcare network. 8. Froedtert to acquire majority stake in Wisconsin hospital Wauwatosa, Wis.-based Froedtert Health plans to acquire a majority stake in Manitowoc, Wis.-based Holy Family Memorial. 9. Rochester Regional, St. Lawrence Health System finalize partnership Rochester (N.Y.) Regional Health, a five-hospital system, and St. Lawrence Health System, a three-hospital system in Potsdam, N.Y., have finalized an affiliation agreement.
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.